Phase 3 Study of Nogapendekin Alfa Inbakicept Plus Standard of Care vs Standard of Care in First-Line Advanced or Metastatic NSCLC

Clinical trial NCT07524257 · WITHDRAWN

Trial details

NCT number: NCT07524257
Sponsor: ImmunityBio, Inc.
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

NSCLC (Advanced Non-small Cell Lung Cancer)Metastatic NSCLC

Start date: 2026-05-29
Primary completion: 2029-05-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.